Trademark: 97864394
Word
FYDIMNI
Status
Registered
Status Code
700
Status Date
Tuesday, April 2, 2024
Serial Number
97864394
Registration Number
7346615
Registration Date
Tuesday, April 2, 2024
Mark Type
4000
Filing Date
Thursday, March 30, 2023
Published for Opposition
Tuesday, January 16, 2024

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Apr 2, 2024
Notice Of Registration Confirmation Emailed
Apr 2, 2024
Registered-Principal Register
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2024
Published For Opposition
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Dec 13, 2023
Approved For Pub - Principal Register
Dec 11, 2023
Assigned To Examiner
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
Apr 23, 2023
New Application Office Supplied Data Entered
Apr 3, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24